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Membrane association is believed to be a prerequisite for the biological activity of the HIV-1 pathogenicity factor Nef. Attachment to cellular
membranes as well as incorporation into detergent-insoluble microdomains (lipid rafts) require the N-terminal myristoylation of Nef. However,
this modification is not sufficient for sustained membrane association and a specific raft-targeting signal for Nef has not yet been identified. Using
live cell confocal microscopy and membrane fractionation analyses, we found that the N-terminal anchor domain (aa 1–61) is necessary and
sufficient for efficient membrane binding of Nef from HIV-1SF2. Within this domain, highly conserved lysine and arginine residues significantly
contributed to Nef 's membrane association and localization. Plasma membrane localization of Nef was also governed by an additional membrane-
targeting motif between residues 40 and 61. Importantly, two lysines at positions 4 and 7 were not essential for the overall membrane association
but critically contributed to Nef 's incorporation into lipid raft domains. Cell surface receptor downmodulation was largely unaffected by mutations
of all N-terminal basic residues, while the association of Nef with Pak2 kinase activity and its ability to augment virion infectivity correlated with
its lysine-mediated raft incorporation. In contrast, all basic residues were required for efficient HIV-1 replication in primary human T lymphocytes
but did not contribute to the incorporation of Nef into HIV-1 virions. Together, these results unravel that Nef 's membrane association is governed
by a complex pattern of signature motifs that differentially contribute to individual Nef activities. The identification of a critical raft targeting
determinant and the functional characterization of a membrane-bound, non-raft-associated Nef variant indicate raft incorporation as a regulatory
mechanism that determines the biological activity of distinct subpopulations of Nef in HIV-infected cells.
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The Nef protein encoded by the primate lentiviruses HIVand
SIV augments virus replication in vivo and thus increases the
pathogenic potential of these viruses. This impact on the
development of infection-associated disease most likely reflects
combinatorial effects of Nef on target host cells that
synergistically optimize virus replication. These activities
include immune evasion mechanisms leading to escape of
recognition of infected cells by cytotoxic T-cells (Collins et al.,
1998; Schwartz et al., 1996; Xu et al., 1999), decreased MHC-II⁎ Corresponding author. Fax: +49 6221 565003.
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doi:10.1016/j.virol.2006.07.003restricted antigen presentation and prevention of IgG class
switching (Qiao et al., 2006; Stumptner-Cuvelette et al., 2001,
2003). Nef also impacts directly on the intrinsic replicative
potential of these viruses by, e.g., augmenting virion infectivity,
extending the life span of infected cells, preventing super-
infection and sensitizing T lymphocytes for activation and thus
HIV replication (Aiken and Trono, 1995; Benson et al., 1993;
Fortin et al., 2004; Keppler et al., 2006; Michel et al., 2005;
Schwartz et al., 1995; Wolf et al., 2001). Nef exerts this
multitude of effects by interfering with vesicular sorting and
signal transduction processes as well as via its ability to act as an
adaptor molecule for select cellular pathways (Arora et al.,
2002; Geyer et al., 2001; Tolstrup et al., 2004).
Although Nef exerts an astonishingly high number of
activities via a complex array of distinct molecular mechanisms,
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activity: First, Nef affects cellular machines by interaction
with target proteins. As expected from its pleiotropic effector
functions, the dynamic regulation of Nef's activities involves a
steadily increasing number of cellular interaction partners
(Geyer et al., 2001; Saksela, 2004; Tolstrup et al., 2004).
Second, its association with cellular membranes is believed to
be essential for virtually all of its effects in infected cells. Based
on membrane fractionation analyses, a significant fraction of
Nef is associated with cellular membranes but Nef is also
distributed in the cytosol without apparent membrane associa-
tion (Bentham et al., 2006; Coates et al., 1997; Fackler et al.,
1997; Kaminchik et al., 1994; Niederman et al., 1993).
Confocal microscopy suggested that most of the membrane-
bound Nef protein associates with yet undefined intracellular
membranous organelles while a minor fraction of Nef is
localized at the inner leaflet of the plasma membrane (Bentham
et al., 2006; Craig et al., 2000; Fackler et al., 2006; Greenberg et
al., 1997; Keppler et al., 2005). While it is unclear what
determines the association of Nef with select membrane
compartments, Nef's overall membrane attachment is primarily
governed by its N-terminal myristoyl moiety. Consequently,
Nef mutants that lack the N-terminal myristoylation because of
mutations of the myristoyl-acceptor glycine at position 2
display at least significantly reduced biological activity in
most assays for Nef function (reviewed in Geyer et al., 2001).
However, studies on other cytosolic proteins that are tethered to
cellular membranes revealed that myristoylation alone is
insufficient to provide sustained membrane association and
several additional signals that increase membrane affinity and
sometimes provide specificity for select membrane compart-
ments within cells were identified (Resh, 1999, 2004). These
“second signals” include additional fatty acid modifications
such as palmitoylation in the case of Src family kinases (e.g.,
Fyn, Yes and Lck) or protein interaction sites as with the
interaction of caveolin with GαI (Galbiati et al., 1999; McCabe
and Berthiaume, 1999; McCabe and Berthiaume, 2001; Resh,
1999). Alternatively, a cluster of basic amino acids downstream
of the myristoylated N-terminus facilitates membrane associa-
tion of, e.g., kinases of the Src family or the HIV-1 Gag protein
(Resh, 1999, 2004). Consistent with this scenario, myristoyla-
tion of Nef was recently shown not to be the only determinant
for Nef's attachment to cell membranes and for its incorpora-
tion into HIV-1 particles (Bentham et al., 2006; Fackler et al.,
2006). Rather, combinatorial membrane targeting via the
myristoyl moiety and basic residues, together also referred to
as SH4 domain, has been proposed for the Nef protein of
HIVQ1NL4-3 (Welker et al., 1998). In this case, lysine as well as
arginine residues in the Nef N-terminus contribute to its
membrane binding and virion incorporation, as well as to effects
on virus replication and cell surface CD4 exposure (Bentham
et al., 2006; Welker et al., 1998). In contrast, we recently found
that for Nef from HIV-1SF2, N-terminal arginine residues are
dispensable for its biological activity in HIV-1-infected
TQlymphocytes (Fackler et al., 2006), suggesting the existence
of further signature motifs that determine Nef's membrane
association.In addition to its association with select cell membranes, a
subpopulation encompassing approximately 5% of total Nef
protein is incorporated into detergent-resistant microdomains
(lipid rafts) (Alexander et al., 2004; Krautkramer et al., 2004;
Sol-Foulon et al., 2004; Wang et al., 2000; Zheng et al., 2001).
While this association also critically depends on Nef 's
myristoylation, specific determinants for raft incorporation
have not been identified to date. The lack of such specificity
significantly complicated investigations on the biological
relevance of the raft-associated Nef population. Using Nef
variants that were artificially enriched in lipid raft domains due
to an additional palmitoylation site, we reported that raft
incorporation of Nef is essential for its ability to associate with
Pak2 kinase activity (Krautkramer et al., 2004). In contrast,
effects of Nef on modulation of surface receptors such as CD4
and MHC-I as well as enhancement of virion infectivity were
shown to be independent of lipid rafts by using an identical
experimental approach (Sol-Foulon et al., 2004).
In this present study, we set out to define the membrane
binding determinants of Nef from HIV-1SF2 using life cell
confocal microscopy and membrane fractionation analyses. We
report that the N-terminal anchor domain of Nef is sufficient for
efficient membrane attachment and that an N-terminal basic
cluster consisting of lysine and arginine residues contributes to
membrane association of Nef. However, this support of
membrane binding was dispensable for Nef's biological activity
in receptor modulation and virion incorporation. In contrast, the
lysine residues were specifically required for raft incorporation
of Nef and essential for Nef's association with Pak2 activity,
enhancement of virion infectivity and virus replication in
primary human T lymphocytes. Together, these results establish
that select Nef activities require differential membrane binding
avidities, characterize a specific raft incorporation determinant
in Nef and shed further light on the role of lipid rafts in the
biological activity of the HIV pathogenicity factor.
Results
The N-terminal anchor domain is necessary and sufficient for
membrane association of HIV-1SF2 Nef
The overall three-dimensional organization of the HIV-1 Nef
protein is governed by three distinct structural entities: the
largely unstructured N-terminal anchor domain (aa 1–61 in the
case of Nef from HIV-1SF2), a well folded core domain (aa 62–
210) and a C-terminal flexible loop (aa 152–184) (reviewed in
Geyer et al., 2001; Geyer and Peterlin, 2001). Efficient
membrane association of Nef is thought to determine its
functionality and to depend on its N-terminal myristoylation.
However, myristoylation alone provides insufficient avidity for
sustained membrane association in cells and Nef must therefore
employ additional targeting motifs for membrane anchorage
(Resh, 1999, 2004). A stretch of arginine residues near the Nef
N-terminus is thought to participate in mediating membrane
association of Nef from HIV-1NL4-3 (Bentham et al., 2006;
Welker et al., 1998). We recently described that these arginine
residues are not essential for the biological activity of Nef from
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therefore set out to identify the membrane binding determinants
of Nef from HIV-1SF2. This allele is widely used as a prototypic
HIV-1 Nef variant due to its high biological activity in all assay
systems analyzed thus far (Arora et al., 2000; Baur et al., 1994;
Fackler et al., 2001; Keppler et al., 2005; Krautkramer et al.,
2004; Renkema et al., 1999).
In order to directly compare the subcellular localization of
Nef in living cells with its membrane association determined
by biochemical approaches, we generated a series of
expression constructs for Nef proteins fused to GFP (Nef.
GFP) (Fig. 1). In line with a recent report (Bentham et al.,
2006), metabolic labeling experiments with tritium-labeled
myristic acid did not reveal significant differences in the
relative degree of myristoylation between these constructs in
human cells (data not shown). We first attempted to narrow
down the region of Nef that bears the major membrane
binding determinants by using various Nef fragments fused to
GFP. These included the anchor (henceforth referred to as 1–
61) and core (62–210, carrying an additional myristoylation
signal) domains of Nef as well as individual fragments of its
N-terminal anchor (1–29, 1–40, 1–50). Full-length SF2 Nef
(wt) and its non-myristoylated variant (G2A) served as
references. Live cell imaging of transfected HeLa cells was
employed to avoid the artificial reduction of apparent
membrane association of SH4 domain containing proteins
observed upon cell fixation (McCabe and Berthiaume, 1999)
(Fig. 2A). Confocal microscopy of wt, expectedly, revealedFig. 1. Schematic representation of Nef.GFP expression constructs used in this study
and amino acids targeted by mutagenesis in this study: myristoylation-acceptor gl
consisting of K4 and K7, one comprised of R 17, 19, 21 and 22), M10, W5 and W13
Numbers indicate amino acid positions in Nef.its association with membranous organelles, vesicular struc-
tures in the cytoplasm as well as a diffuse cytosolic
distribution. Importantly, this real-time analysis also revealed
a prominent association of Nef with the plasma membrane
that was slightly more apparent than in fixed samples (data
not shown). In line with the proposed role of myristoylation
in Nef's membrane attachment, G2A was found not to be
enriched at cellular membranes and was rather distributed
homogenously throughout the cell. This distribution was
virtually indistinguishable from that of GFP alone, suggesting
that the presence of G2A in the nucleus reflects the
karyophilic properties of the GFP moiety of the fusion
protein. A similar pattern was also observed for 62–210,
demonstrating that the core domain of Nef does not
significantly contribute to its membrane attachment and that
myristoylation alone is insufficient for membrane targeting of
the core domain. In contrast, the anchor domain 1–61
efficiently targeted GFP to cellular membranes with a strong
specificity for the plasma membrane while only a weak
diffuse cytoplasmic distribution was observed. This pro-
nounced plasma membrane localization was also observed
with the fragments 1–50 and 1–40, although membrane
association appeared increasingly less prominent with
decreasing length of the Nef fragment analyzed. The gradual
loss of membrane association was most apparent with
fragment 1–29, which was evenly distributed throughout the
cell including some localization at the plasma membrane.
Together, the N-terminal anchor of Nef contains all signals for. Depicted at the top is Nef.GFP from HIV-1SF2 (wt) with the structural domains
ycine at the N-terminus (depicted by the fanfold tail), two basic clusters (one
, and the alpha helix within the anchor domain of Nef (aa 38–45: SRDLEKHG).
Fig. 2. Subcellular localization of different Nef.GFP fragments in transfected HeLa cells. (A) Live cell imaging of HeLa cells transiently expressing the indicated Nef.
GFP proteins. 24 h post-transfection cells were analyzed by confocal microscopy. Individual representative z-sections are presented. Scale bar=10 μm. (B) Membrane
fractionation of HeLa cells analyzed in panel A. 24 h post-transfection, postnuclear extracts were fractionated into soluble (S) and pellet (P) fraction and analyzed by
Western blotting for the distribution of Nef.GFP. (IN) designates unfractionated cell lysates as input control. Note that the electrophoretic mobility of various Nef.GFP
fragments differs significantly due to their size differences. Transferrin receptor (TfR) and 14-3-3 proteins were analyzed as markers for S and P fractions, respectively.
(C) Quantification of the membrane fractionation analysis presented in panel B. Shown is the relative distribution of the various Nef.GFP proteins into S and P fractions
with the total signal from both fractions set to 100%. Data represent average values from at least three independent experiments with the indicated standard error of the
mean. The statistical significance of the differences in the relative distribution to the P fraction for the indicated Nef mutants relative to the wt Nef control was analyzed
by Student's t test (***P<0.0005; **P<0.005; *P<0.05).
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domain bears determinants for its recruitment to intracellular
membranous organelles.
Within the anchor domain, our observations suggested that
the stretch between residues 29 and 61 contains a determinant
for plasma membrane targeting of Nef that synergizes with its
N-terminal myristoylation. We next compared these results with
the distribution of the various Nef.GFP proteins upon
biochemical fractionation (Fig. 2B). Postnuclear extracts of
transfected HeLa cells were subjected to ultracentrifugation and
separated into a soluble fraction containing all cytosolic
components (S) and a pellet fraction that bears membranes,
cytoskeleton and protein aggregates (P) (Niederman et al.,
1993; Tritel and Resh, 2000). The cytoplasmic 14-3-3 protein
and the transmembrane transferrin receptor (TfR) were used as
quality control for S and P, respectively. While consistently no
contamination of the P fraction by soluble material was
detected, minor contaminations of the S fraction with TfR
were occasionally observed. Consistent with previous reports
on non-fusion Nef proteins in transfected HeLa cells or HIV-1-
infected Jurkat T lymphocytes (Bentham et al., 2006; Fackler et
al., 2006) and thus validating the use of GFP fusion proteins for
this analysis, wt Nef.GFP was found to 30% in the pellet
fraction and this was significantly reduced, but not fully
abrogated, for the non-myristoylated G2A variant (10% in P)
(Fig. 2C). Consistent with our imaging analysis, 62–210 was
detected in P with an efficiency comparable to G2A and 1–61
was strongly enriched in the membrane fraction (73%). The
shorter anchor fragments segregated in the P fraction with
intermediate efficiency (50–57%). Of note, the relative amounts
of 1–29 in P were comparable to those of 1–40 and 1–50
despite the lack of a pronounced plasma membrane localization
of the short fragment, suggesting that 1–29 was predominantly
targeted to intracellular membranes or included in protein
aggregates. Together, the results of the imaging and fractiona-
tion analyses roughly correlated and emphasize the existence of
a determinant for plasma membrane targeting signal in Nef
between residues 29 and 61.
Basic residues in the anchor domain synergistically contribute
to Nef Ts membrane association
We next analyzed the involvement of N-terminal residues
with putative membrane affinity in the membrane attachment of
Nef. First, the basic amino acids previously implied in
membrane binding of Nef from HIV-1NL4-3 were mutated to
alanine resulting in the KK and R4 Nef variants, carrying the
(K4/7A) and (R17/19/21/22A) mutations, respectively. A
combinatorial KR mutant with all lysine and arginine residues
mutated to alanine was also generated. Since methionine and
tryptophane residues can also mediate interactions at protein-
membrane interfaces (Wimley and White, 1996), W5 and W13
were targeted by alanine mutagenesis either alone to yield the
WW mutant or in combination with M10 (WMW). Finally, a
combinatorial Nef variant of the WMW and R4 mutants (WR)
and a deletion mutant lacking a putative amphipathic helix that
serves as the interaction site for NAKC and AP-1/MHC-Icomplexes (Δ12–39) (Baur et al., 1997; Roeth et al., 2004)
were generated. All these Nef.GFP proteins were expressed to
comparable levels, suggesting that the introduced mutations did
not significantly affect protein stability (see Fig. 3B). Notably,
mutations of the lysine residues slightly accelerated the
electrophoretic mobility of Nef.GFP. Real-time confocal
microscopy revealed that all these mutations slightly decreased
the apparent association of Nef.GFP with the plasma membrane
and increased the diffuse cytosolic distribution (Fig. 3A). These
effects were most pronounced for Nef variants lacking the
stretch of arginines (R4, KR and Δ12–39). In contrast,
mutations in the W and K residues had less influence on
Nef's subcellular distribution. Surprisingly, despite mutation of
the arginines, WR displayed a subcellular distribution that was
comparable to that of wt, suggesting that the additional mutation
of the tryptophanes somehow compensated for the lack of the
arginines. Nevertheless, these results demonstrate that the
arginine residues in the N-terminus of Nef SF2 play a
significant role for its localization in living cells. Comparable
results were obtained with the biochemical membrane fractio-
nation analysis (Figs. 3B and C). Mutations of the tryptophane
or lysine residues did not significantly affect the distribution
between soluble and pellet fractions and the loss of the positive
charges provided by the arginine stretch caused a moderate, but
significant reduction in the association of Nef with the
membrane pellet. To illustrate the inter-experimental variability
in the distribution of Nef to the P fraction, two experiments are
presented for KK that represent the minimal and maximal pellet
association observed. In contrast, the KR variant almost
completely failed to associate with the pellet fraction and was
consistently found to be even more enriched in the cytosolic
fraction than G2A. The fact that Δ12–39 retained considerable
membrane affinity in the biochemical assay and plasma
membrane localization in living cells together with our previous
results with the N-terminal Nef fragments suggested that
residues 40–61 contain an additional determinant for plasma
membrane localization of Nef. This stretch contains a series of
charged residues that form a short alpha helix (Geyer et al.,
1999). In order to define the targeting motif involved, a series of
deletions and point mutations of positively or negatively
charged residues was generated, however, poor stability of all
resulting Nef.GFP fusion proteins precluded further analysis
(data not shown). Together, these analyses demonstrate that
basic residues in the N-terminus of Nef significantly contribute
to its membrane affinity.
N-terminal lysines are critical for lipid raft incorporation of
Nef
Besides myristoylation, specific determinants that govern
Nef's incorporation into lipid rafts have not yet been identified.
We addressed this question with our combined imaging and
biochemical fractionation approach. As described before
(Krautkramer et al., 2004), lipid rafts were visualized in
transfected Jurkat T-cells via clustering of fluorescently labeled
cholera toxin (CTx) (Fig. 4A) and these results were compared
to those from raft flotation analysis after Triton X-100 based
Fig. 3. Subcellular localization of different Nef.GFP mutants in transfected HeLa cells. (A) Live cell imaging of HeLa transiently expressing the indicated Nef.GFP
proteins. Scale bar=10 μm. (B) Membrane fractionation of HeLa cells analyzed in panel A. The relative distribution of the Nef variants in the P fraction was quantified
from the blots presented to wt: 27%, G2A: 2%, WW: 41%, WMW: 39%, WR: 21%, Δ12–39: 22% (upper panel) and wt: 28%, G2A: 23%, KK: 11%, R4: 25%, KR:
5%, KK: 35% (lower panel). (C) Quantification of at least three independent membrane fractionation analyses. All analyses were performed as described in the legend
to Fig. 2. The statistical significance of the differences in the relative distribution to the P fraction for the indicated Nef mutants relative to the wt Nef control was
analyzed by Student's t test (***P<0.0005; **P<0.005; *P<0.05).
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Fig. 4. Raft localization of different Nef.GFP constructs. (A) Clustering of Nef.GFP with lipid rafts. 24 h post-transfection, Jurkat T-cells transiently expressing the
indicated Nef.GFP proteins were subjected to raft clustering by incubation with Cholera Toxin (CTx) conjugated with Alexa-594 (KK) or Alexa-555 (all others)
fluorescent dyes, respectively, and subsequently crosslinked with anti-CTx antibody. Cells were analyzed by confocal microscopy and single representative sections are
presented. The merge panel depicts the overlay of both fluorescence channels. (B) Lipid raft flotation analysis from transfected 293Tcells expressing different Nef.GFP
fusion proteins. Cell lysates (1%TritonX-100) were separated byOptiprep gradient ultracentrifugation, and eight fractions were collected from the top (fraction 1) to the
bottom (fraction 8) of the gradient. The detergent-resistant membrane fraction (DRM, fraction 2) and the pooled non-raft fractions (NR, fractions 7 and 8) were analyzed
together with the unfractionated cell lysate (L) by Western blotting for the distribution of Nef.GFP. TfR and caveolin were analyzed as markers for NR and DRM
fractions, respectively.
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Fig. 5. Downregulation of CD4, MHC-I and CCR5 by various Nef.GFP
mutants. CHO hCD4hCCR5 cells and TZM clone 13 cells, respectively, were
transfected with expression constructs for the indicated Nef.GFP proteins. 24 h
post-transfection live cells were stained for surface expression with allophyco-
cyanin (APC)-conjugated antibodies against human CD4 or human CCR5
(CHO hCD4hCCR5 cells) or with phycoerythrin (PE)-conjugated antibodies
against human HLA-ABC antigen (TZM clone 13 cells), respectively. Steady-
state cell surface levels of corresponding receptors were determined by flow
cytometry analyzing the mean fluorescence intensities (MFI) in viable cells with
medium- to high-level expression of GFP. Values from only GFP transfected
cells were arbitrarily set to 1. Data are mean±SD of at least 3 independent
experiments. The statistical significance of the differences in cell-surface levels
in the presence of the indicated Nef mutants relative to the wt Nef control was
analyzed by Student's t test (***P<0.0005; **P<0.005; *, P<0.05).
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caveolin in the detergent-resistant membrane (DRM) fraction
and of TfR in the non-raft (NR) fractions served as control for
the raft flotation procedure. Expectedly, wt was found to
partially co-localize with CTx-positive raft clusters at the
plasma membrane and to be present in DRM fractions in a
myristoylation-dependent manner (compare wt and G2A in
panels A and B). As in the membrane binding analysis, 1–61
was even more efficiently incorporated into raft domains than
wt and the behavior of 62–210 was comparable to that of G2A.
The residual amounts of the 62–210 and G2A Nef variants in
the DRM fraction in this particular experiment most likely
reflects the slight contamination of the DRMs with non-raft
material (see presence of TfR in DRM). Raft incorporation of
Nef was primarily governed by the far N-terminus of Nef as 1–
29 was readily recruited into raft clusters and DRMs (data not
shown). Importantly, the KK Nef mutant was specifically
excluded from DRMs (Fig. 4B) and, although still present in
dotted structures at the plasma membrane, only minimal co-
localization of KK could be detected with raft clusters in Jurkat
T-cells (Fig. 4A). Mutation of the other N-terminal basic
residues did not affect Nef's association with raft clusters or
DRMs (data not shown). Since all these Nef variants displayed
comparable overall membrane association, the incorporation of
Nef from HIV-1SF2 into raft domains is mediated specifically by
the two N-terminal lysine residues. Together, these results
reveal that membrane attachment and raft incorporation of Nef
are governed by distinct signals and identify the two N-terminal
lysines as specific determinant for the incorporation of Nef into
detergent-resistant microdomains.
Downmodulation of select cell surface receptors requires
differential avidity of membrane attachment of Nef
As a first functional correlate for the association of the
various Nef mutants with cellular membranes, we tested their
ability to downmodulate the surface exposure of CD4, MHC-I
and CCR5 in TZM or CHO hCD4hCCR5 cells, respectively
(Fig. 5) (Garcia and Miller, 1991; Michel et al., 2005; Schwartz
et al., 1996). As described before (Michel et al., 2005), cell
surface levels of the individual receptors were determined on
living cells by flow cytometry and the mean fluorescence
intensities were compared between untransfected (GFP-nega-
tive) cells and cells expressing medium to high levels of GFP or
Nef.GFP. All values were plotted relative to the GFP negative
control. As expected, wt Nef.GFP downmodulated all three
receptors, albeit with different efficiency (80% for CD4, 38% for
MHC-I and 63% for CCR5). The AxxA mutant, which is
specifically defective in downmodulating MHC-I and CCR5,
and the EDAA Nef variant, that is impaired in reducing cell
surface CD4 levels, were used as specific controls. Of note, all
Nef mutants with modifications in the N-terminal motifs
retained full CD4 downregulation activity, while the activity of
non-myristoylated G2A was partially reduced. Of note and in
line with our results in HIV-1-infected T lymphocytes (Fackler et
al., 2006), the G2A mutation did not have appreciable effects on
Nef's ability to downmodulate cell surface MHC-I. Consis-tently, modification of putative membrane interacting residues in
the anchor domain also did not impair this Nef activity. A yet
slightly different scenario was obtained when the activity of
these Nef variants on cell surface CCR5 was analyzed: While
myristoylation significantly contributed to this Nef effect (G2A
reduced CCR5 levels by only 30%), tryptophane and arginine
residues were fully dispensable. In contrast, simultaneous
mutations of lysine and arginine residues in KR caused a slight
but significant reduction of Nef's ability to downregulate CCR5
(downregulation of CCR5 levels by 40%). Together, membrane
association correlates to different degrees with the ability of Nef
to downmodulate cell surface levels of CD4, MHC-I and CCR5.
Lysine residues in the N-terminus of Nef are critical for its
association with Pak2 activity
To address the role of membrane association for signal
transduction properties of Nef, we analyzed its ability to asso-
ciate with cellular Pak2 kinase activity in Jurkat T lymphocytes
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et al., 1999; Sawai et al., 1994). Following immunoisolation
of various Nef.GFP fusion proteins and subsequent in vitro
kinase (IVKA) reaction, Nef-associated phosphorylated Pak2
was visualized by autoradiography (Fig. 6, IVKA). Expression
levels of the various Nef.GFP proteins were comparable as
judged by Western blot analysis (Fig. 6, input). The bottom
panel of Fig. 6 presents the quantification of the Nef-
associated Pak2 activity based on the intensity of the
autophosphorylated Pak2 band. It would be desirable to
correlate the phospho-Pak2 levels with the amounts of
immunoisolated Nef. However, this analysis was precluded
for the Nef variants with lysine residues mutated because their
co-migration with the antibody heavy chain prevented accurate
quantification. In those cases where the normalization of
phospho-Pak2 intensities for the amounts of Nef.GFP present
in the immunoisolates was possible, relative differences similar
to those presented were observed (data not shown). Expectedly,
wt readily associated with robust amounts of Pak2 activity
while the negative controls GFP and AxxA did not reveal
specific Pak autophosphorylation products (24% and 20%
activity). Of note, the association of G2Awith Pak2 activity was
also drastically impaired (16% activity). In contrast, trypto-
phane and arginine residues were entirely dispensable for the
association of Nef with Pak2 activity and mutations of the
arginines even increased the activity of Nef. This increase in
association with Pak2 activity did not stem from an augmented
raft incorporation of the R4 Nef variant (data not shown). Thus,
the loss of these positively charged residues, possibly byFig. 6. Nef.GFP-associated Pak2 activity of wt Nef.GFP and various Nef.GFP m
immunoprecipitated with anti-GFP antibodies and subjected to an in vitro kinase ass
activity is revealed by the autophosphorylated kinase (p-Pak2). Western blot analysis
of Nef.GFP expression levels (input). The bottom panel presents the quantification of
were quantified by phosphorimager using QuantityOne software. Values for wt Ne
experiments. The statistical significance of the differences in Nef-associated autopho
Nef control was analyzed by Student's t test (***P<0.0005; **P<0.005; *P<0.05affecting protein conformation, may somehow facilitate the
interaction of Nef with Pak2 or other components of the Nef–
Pak2 complex. In contrast, mutations of the lysine residues
markedly reduced the association of Nef with active Pak2 (49%
and 54% activity for KR and KK, respectively). Together,
membrane attachment is a strict requirement for Nef's ability to
associate with Pak2 activity and the lysine residues in the N-
terminus of Nef were identified as a novel determinant of this
Nef activity.
Virus replication and virion incorporation
Our previous analyses demonstrated that the R4 mutant of
SF2 Nef is readily incorporated into HIV-1 virions and displays
wt activity in the enhancement of virion infectivity as well as in
boosting HIV-1 replication in primary human T-lymphocytes
(Fackler et al., 2006). To analyze the role of all N-terminal
membrane targeting signals in these functional assays, isogenic
viruses using the HIV-1NL4-3 proviral backbone were con-
structed that encode for the WR, KK and KR variants of SF2
Nef. A virus expressing wt SF2 Nef (wt) and a nef-deleted
variant (Δnef) served as controls. Virus was produced in 293T
cells following transfection of the indicated proviral DNAs and
resulted in the production of comparable amounts of virus
particles for all constructs (data not shown). Western blot
analysis of transfected 293T cells revealed similar levels of
expression for all Nef variants and comparable patterns of Gag
processing (Fig. 7A). When HIV particles were pelleted from
these cell culture supernatants (Fig. 7B), comparable amountsutants. 24 h post-transfection, postnuclear supernatants of Jurkat T-cells were
ay (IVKA) analysis. Presented is an autoradiograph where Nef-associated Pak2
of the cleared lysates used for immunoprecipitation was performed for evaluation
the Nef-associated Pak2 activity. Intensities of autophosphorylated Pak2 signals
f.GFP were arbitrarily set to 1. Data are mean±SD of at least 3 independent
sphorylated Pak2 in the presence of the indicated Nef mutants relative to the wt
).
Fig. 7. Influence of different Nef.GFP proteins on virion incorporation, enhancement of virion infectivity and HIV-1 replication. (A) Western blot analysis of lysates
from 293T cells 48 h post-transfection with the indicated proviral constructs for virus production. Cells were harvested and analyzed for the expression of Gag (upper
panels) and Nef (lower panels). Arrows indicate unprocessed Gag (p55), CA or Nef, respectively. (B) Virion incorporation of Nef variants. Western blot analysis of
virus pellets generated by ultracentrifugation of cell culture supernatants from 293T cells that had been transfected with the respective proviral clones for virus
production. Note that 5 ng or 100 ng total protein were loaded for the analysis of CA (upper panel) or Nef (lower panel), respectively. (C) Single round of replication
analysis on TZM cells. TZM cells were infected with 0.5 ng CA of the identical virus stocks that were analyzed for Nef virion incorporation in panel B. 36 h post-
infection, the cells were fixed, stained for β-galactosidase activity and the number of blue cells was counted. Data represent average values from two independent
experiments with triplicate measurements each with the indicated standard error of the mean. Depicted is the relative virion infectivity (number of blue cells per ng CA)
with values for HIV-1NL4-3 NefSF2 (wt) arbitrarily set to 100%. (D) Effects of Nef mutants on HIV-1 replication in PBL. HIV replication was measured in 96-well
plates on 1×105 PBL per well and 1 ng CAvirus input. Freshly isolated, non-activated cells were infected (day −6) for three days and subsequently activated by PHA/
IL-2 for three days. Starting from day 0, cells were kept in the presence of IL-2 and cell culture supernatants were collected each day to monitor CA production. CA
values represent the average from quadruplicate infections performed in parallel.
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in virions. Thus, consistent with our previous findings on virion
incorporation of the G2A variant of SF2 Nef (Fackler et al.,
2006), neither the reduced membrane binding capacity of the
KR mutant nor the reduced lipid raft incorporation of the Nef
KK caused an appreciable reduction of Nef's incorporation into
virus particles. In contrast, marked differences were observed in
the relative infectivity of virions in a single round of infection
on TZM reporter cells (Fig. 7C). 36 h following infection with
0.5 ng p24CA, wt was approximately 10-fold more infectious
than Δnef. Of note, the WR mutant increased virion infectivity
as efficiently as wt, indicating that the tryptophanes and the
arginines are dispensable for Nef's effect on virion infectivity.
In contrast, both Nef variants in which K4 and K7 were mutated
(KK and KR) were significantly impaired in enhancing HIV-1
virion infectivity. This effect was most pronounced for KK Nef
that was almost completely inactive in this assay. These findings
suggest that incorporation of Nef into lipid rafts may be
instrumental for its effect on virion infectivity. Finally, the effect
of these Nef variants on HIV-1 replication in primary human
PBMCs was analyzed. According to previous studies (Fackler
et al., 2006; Welker et al., 1998), resting PBMCs were infected,
subsequently activated by PHA/IL-2 for 3 days and HIV-1
replication was monitored over time (Fig. 7D). Under theseexperimental conditions, HIV-1 replication was significantly
reduced in the absence of Nef during the first two days and
subsequently reached levels of p24 production comparable to
those of wt (Fig. 7D, compare wt and Δnef). Interestingly, all
three Nef variants analyzed failed to increase HIV-1 replication
over the level of Δnef during this time period and were thus
considered inactive in augmenting virus replication in primary
human T lymphocytes.
Discussion
The present study identifies membrane binding determinants
of HIV-1SF2 Nef in human cells and unravels their individual
contribution to Nef 's biological activity. Based on the
microscopic and biochemical analyses presented, membrane
association of the viral protein requires its N-terminal
myristoylation, basic arginine and lysine residues near the
NQterminus and at least one additional motif in the N-terminal
anchor domain. Importantly, two N-terminal lysine residues
were found to be critical also for the incorporation of Nef into
lipid rafts. Host cell signal transduction as well as most receptor
sorting processes were modulated with maximum efficiency
only by Nef variants with full membrane association capacity.
As summarized in Table 1, individual Nef functions were
Table 1
Summary of localization and activities of the HIV-1SF2 Nef proteins analyzed
Nef
variant
Fractionation DRM/raft
association
CD4
↓
MHC-I
↓
CCR5
↓
Pak2
association
Virion
incorporation
Infectivity
enhancement
PBL
replication
S [%] P [%]
wt 67±5 33±5 + + + + + + + +
G2A 86±7 14±7 − +/− +/− +/− − + − −
1–29 48±15 52±15 + n.d. n.d. n.d. n.d. n.d. n.d. n.d.
1–40 49±9 51±9 n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d.
1–50 43±6 57±6 n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d.
1–61 27±17 73±17 + n.d. n.d. n.d. n.d. n.d. n.d. n.d.
62–210 82±4 18±4 − n.d. n.d. n.d. n.d. n.d. n.d. n.d.
Δ12–39 76±6 24±6 n.d. n.d. n.d. n.d. +/− a − b −b −b
WW 66±9 34±9 n.d. + + + + n.d. n.d. n.d.
WMW 70±13 30±13 n.d. + + + + n.d. n.d. n.d.
R4 76±1 24±1 + + + + ++ +b +b +b
WR 75±8 25±8 + + + + + + + −
KK 75±12 25±12 − + + + − + − −
KR 96±2 4±2 − + + + +/− + +/− −
+ indicates activity comparable to the wt protein, − designates loss of function, +/− intermediate activity and ++ increased activity relative to wt HIV-1SF2 Nef. Nef
fragments were not tested in functional assays because of the lack of relevant domains/motifs that mediate the activity of the full-length Nef protein.
a Baur et al. (1997).
b Fackler et al. (2006).
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association or raft incorporation. While we cannot exclude that
the mutations introduced cause effects in addition to the
observed alterations in membrane association, these findings
imply membrane interactions and segregation into raft-like
domains as a critical regulatory mechanism for Nef's activities
in the infected host.
The data presented reveal that the N-terminal anchor is
sufficient for the association of Nef with cellular membranes.
Indeed, the Nef anchor fragments of various length tethered
their GFP fusion moiety to membranes with even higher
efficiency than the full-length Nef protein. Thus, the core
domain of Nef, presumably because of its relatively large mass
and volume, the lack of specific membrane targeting signals and
the presence of specific sorting motifs, somewhat counteracts
the membrane association of the N-terminus of Nef, thereby
resulting in the steady state distribution of Nef observed.
Alternatively, Nef may undergo a conformational change
between its membrane-bound and cytosolic form such that the
N-terminal fatty acid interacts with the core domain to facilitate
its solubilization as recently suggested (Breuer et al., 2006).
Truncation of the core domain would hence lead to increased
exposure of the myristate. In line with this scenario, the
myristoylated anchor of Nef is significantly less soluble in vitro
than the myristoylated full-length protein (Breuer et al., 2006;
Geyer et al., 1999). Of note, despite the use of different
biochemical procedures by several investigators, the overall
proportion of membrane-associated Nef protein is consistently
estimated to approx. 30% in different mammalian cells using
Nef overexpression or HIV infection (Bentham et al., 2006;
Fackler et al., 1997, 2006; Kaminchik et al., 1994; Niederman et
al., 1993). In contrast, the microscopic analysis of Nef's
subcellular localization in fibroblasts gave variable results
ranging from a relatively diffuse cytoplasmic distribution to a
marked punctuate staining and the association with intracellular
membranous structures (Bentham et al., 2006; Craig et al.,2000; Fackler et al., 2006; Greenberg et al., 1997; Keppler et al.,
2005) but without pronounced localization of Nef at the plasma
membrane. The use of live cell imaging of Nef.GFP in the
present study circumvented artifacts that can be induced by cell
fixation. This analysis revealed a distribution that is consistent
with the biochemical analysis and strongly supports the notion
that substantial amounts of Nef are membrane-associated
including a pronounced localization at the plasma membrane
in intact human cells. The identity of the intracellular Nef-
positive membrane compartment(s) remains unclear. We and
others (Blagoveshchenskaya et al., 2002; Michel et al., 2006;
Piguet et al., 2000) have shown a significant overlap of Nef with
the trans-Golgi network (TGN). However, partial overlap of
Nef with endosomal membrane compartments can also be
conserved at the densely packed perinuclear area in fibroblasts
(data not shown). The limited resolution of confocal micro-
scopy therefore warrants a more refined analysis by, e.g.,
electron microscopy to unambiguously define these membra-
nous compartment(s).
Myristoylation and N-terminal lysine and arginine residues
were critical for Nef`s membrane association and subcellular
localization. In contrast, despite the potential to mediate
protein–membrane interactions (Wimley and White, 1996),
tryptophane and methionine residues near the N-terminus of the
viral protein were dispensable for membrane association and
functionality of the viral protein in human cells. Based on our
analysis with N-terminal Nef fragments and Nef deletion
mutants, Nef contains at least one additional signal in between
amino acids 40–61 that contributes to its plasma membrane
localization. This stretch bears multiple charged amino acids
that form a short alpha helix (Geyer et al., 1999). Some of these
charged residues are reportedly required for the ability of
several HIV-1 Nef proteins to modulate cell surface CD4 but not
MHC-I and MHC-II molecules (Aiken et al., 1996; Casartelli et
al., 2003; Iafrate et al., 1997; Mangasarian et al., 1999;
Schindler et al., 2003). However, these studies did not
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membrane association or subcellular localization and the
characterization of corresponding mutants has not been reported
for SF2 Nef. Unfortunately, similar to a previous report
(Mangasarian et al., 1999), our attempts to analyze the
relevance of these amino acids for membrane association and
function of SF2 Nef were hampered by the instability of all
proteins tested with deletions or point mutations of the
candidate charged residues. Thus, in addition to its role in
subcellular targeting of Nef, this alpha helix likely plays an
important role for the overall structural organization and thus
stability of Nef in human cells.
The functional characterization of the basic cluster in SF2
Nef confirms and extends a recent study by Bentham and
colleagues (2006) on Nef from NL4-3. Both studies agree that
the lysine residues alone do not play a significant role in Nef's
membrane attachment per se and demonstrate that the lysine and
arginine residues together contribute more to Nef's association
with cell membranes than the myristoyl anchor. However, while
the arginines were found to have a significant impact on
membrane binding in biochemical analyses for NL4-3 Nef, the
R4 SF2 Nef mutant behaved almost like wt in our hands. This
difference likely reflects the variability between these Nef
alleles that may be determined by the insertion of four amino
acids in the anchor domain of SF2 Nef (Geyer et al., 2001).
Similarly, when judged by confocal microscopy, the R4
mutation significantly increased a diffuse cytosolic localization
of SF2 Nef in the present study while Bentham et al. (2006)
observed a translocation of the R4 mutant of NL4-3 Nef from
the plasma membrane and the ER/Golgi compartment to
mitochondria. Such allelic differences are also apparent when
the role of the lysine and arginine residues was analyzed for the
capacity of Nef to downmodulate cell surface CD4. While the
arginines were not required for CD4 downregulation by Nef
proteins from the HIV-1 isolates NA-7, NL4-3 and SF2
(Bentham et al., 2006; Iafrate et al., 1997, and this study),
they slightly contributed to the activity of the Nef protein from
HIV-1R8 (Aiken et al., 1996). Similarly, the two lysines were
dispensable for Nef's effects on cell surface CD4 for NL4-3, R8
and SF2 Nef proteins (Aiken et al., 1996; Bentham et al., 2006,
and this study) but contribute to the activity of NA-7 Nef
(Iafrate et al., 1997). Importantly, the combinatorial mutation of
arginines and lysines did not affect the activity of SF2 Nef in
this assay while CD4 downregulation by NL4-3 Nef was
essentially abrogated by the corresponding mutation (Bentham
et al., 2006, and this study). Such differences are also apparent
in the context of infectious viruses: while NL4-3 Nef depends
on its myristoylation and the basic cluster for virion incorpora-
tion, SF2 Nef is incorporated independently of both signals
(Fackler et al., 2006; Welker et al., 1998, and this study) and
infectivity enhancement requires the lysines for SF2 Nef,
whereas the activity of NL4-3 Nef depends on both the
arginines and lysines. Together, this emphasizes that individual
motifs involved in membrane association contribute to different
degrees to the activity of various Nef proteins.
The analysis of lipid raft incorporation of various Nef
mutants allowed us to identify the N-terminal lysine residues asa determinant that is required for efficient raft targeting of Nef
from HIV-1SF2. While the lysines were clearly necessary for the
efficient recruitment of Nef into detergent-resistant microdo-
mains and plasma membrane raft cluster, we cannot exclude that
additional signals participate in the regulation of Nef 's
incorporation into lipid rafts. Given the differences between
various HIV-1 Nef proteins, it remains also open whether this
di-lysine motif acts as a general raft targeting motif for all Nef
variants and how these lysine residues facilitate SF2 Nef's raft
incorporation remains an interesting open topic for future
studies. The mechanism(s) involved may include the methyla-
tion of the two lysine residues or lysine dependent interactions
with raft-resident proteins and/or lipids (Liang et al., 2004;
Resh, 2004). The generation of the KK variant enabled us for
the first time to functionally characterize a membrane-
associated Nef protein that is selectively excluded from raft
domains. Previous studies on the functional relevance of raft-
associated Nef had to rely on gain-of-function Nef variants with
experimentally increased raft association. Arguably more
physiological than the use of a transmembrane anchor
(Alexander et al., 2004), two studies used palmitoylated Nef
proteins (Krautkramer et al., 2004; Sol-Foulon et al., 2004) that
were present with up to 50% in detergent-resistant micro-
domains. This approach demonstrated that augmented raft
incorporation of Nef emphasizes its ability to associate with
Pak2 kinase activity but does not affect its ability to
downmodulate cell surface CD4 and MHC-I receptors or to
boost HIV infectivity and replication. Thus, while the Nef–Pak2
association was found to benefit from Nef's raft incorporation,
this localization was not limiting for these other Nef activities.
The functional analysis of the KK variant extends these earlier
findings by demonstrating that raft incorporation is necessary
for the association of Nef with active Pak2 and fully dispensable
for its effects on cell surface CD4, MHC-I and CCR5. Of note,
raft exclusion of Nef interfered with its ability to augment virion
infectivity, which is in line with an involvement of raft domains
in this Nef activity (Zheng et al., 2001). However, the
incorporation of a small subpopulation of Nef in raft domains
appears sufficient to imprint the increase in infectivity as further
raft enrichment of Nef does not markedly accentuate its ability
to enhance particle infectivity (Sol-Foulon et al., 2004).
Consistent with our previous findings (Fackler et al., 2006),
infectivity enhancement does not correlate with the incorpora-
tion of Nef into infectious virions, which also occurs in a raft-
independent fashion. This may be surprising given that HIV
particles preferentially bud from lipid raft like domains and the
resulting virions are highly enriched in raft lipids (Brugger et
al., 2006). Since neither myristoylation (Fackler et al., 2006) nor
raft targeting is a prerequisite for virion incorporation,
membrane association is highly unlikely to account for the
presence of SF2 Nef in HIV-1 particles. Rather, protein
interactions such as the association of Nef with GagPol
(Costa et al., 2004) might mediate its virion incorporation.
However, as the presence of Nef in HIV-1 particles is neither
necessary nor sufficient to mediate Nef's effects on particle
infectivity and replication, the biological relevance of virion-
associated Nef remains uncertain. Together, these findings
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biological activity of Nef where raft-associated Nef is devoted
to at least some of the signaling activities and to infectivity
enhancement while the modulation of intracellular receptor
transport is governed by the non-raft resident Nef population.
Importantly, membrane association did not correlate equally
well with all Nef activities analyzed. As discussed above, the
association of Nef with active Pak2 is very sensitive to
alterations of Nef's membrane association, presumably reflect-
ing the requirement of lipid raft incorporation for the assembly
of the Nef–Pak2 complex (Krautkramer et al., 2004; Pulkkinen
et al., 2004; Raney et al., 2005). In contrast, effects of Nef on
cell surface receptor modulation required less pronounced
membrane association. Interestingly, CD4 downregulation was
efficiently mediated by the KR mutant that only retains minimal
membrane affinity while the lack of myristoylation, that affects
Nef's overall membrane association to a lesser extend, was
significantly impaired in this activity. This indicates that
myristoylation, e.g., by affecting the overall structural con-
formation of Nef, may be important for processes other than
membrane binding that are relevant for its biological activity. As
Nef is thought to downmodulate CD4 by various mechanisms
that involve the interaction of the viral protein with the CD4
cytoplasmic tail (Aiken et al., 1994; Lama, 2003; Rose et al.,
2005), downmodulation could, in principle, be envisioned
without intrinsic membrane binding of Nef (Bentham et al.,
2003). The latter might also apply to downmodulation of
MHCQI by SF2 Nef which, consistent with our recent results in
HIV-1-infected T lymphocytes (Fackler et al., 2006), did not
require myristoylation or presence of the basic cluster and was
thus the least dependent on membrane association of all Nef
activities analyzed herein. This might reflect that the effects of
Nef on MHC-I surface presentation involve the formation of a
complex between Nef, MHC-I and AP-1 (Roeth et al., 2004;
Williams et al., 2005), which might not require intrinsic
membrane binding by Nef. Of note, relative to the effects on
MHC-I, the downmodulation of CCR5 was more sensitive to a
reduction of Nef's membrane association. We previously
reported that downmodulation of both, MHC-I and CCR5
require identical signature motifs in Nef (Michel et al., 2005).
The differential requirement for membrane attachment provides
a first indication that the mechanisms utilized by Nef to
downmodulate these surface receptors may not be fully identical
and suggests that relative requirements for membrane associa-
tion may be employed to dissect the cellular pathways targeted
by individual Nef activities. Finally and consistent with
previous findings for NL4-3 Nef (Welker et al., 1998), the
positive effects of SF2 Nef on HIV-1 replication in primary
human T lymphocytes were very sensitive to modifications in its
membrane targeting and raft incorporation determinants. This
implies that multiple, both raft-dependent and -independent,
activities are exerted by Nef simultaneously to achieve the
optimization of virus replication thought to be crucial for its role
as pathogenicity factor in vivo.
Together, the findings presented support the idea that Nef
undertakes a journey through the infected cell where multiple
targeting signals determine its localization and thus itsbiological activity. Co-translational myristoylation of Nef
allows prompt membrane targeting by the anchor domain that
contains the myristoyl moiety, basic residues and at least one
additional targeting determinant. Presumably following initial
transport to the plasma membrane, Nef segregates into raft-
resident and non-resident subpopulations with distinct biologi-
cal properties. Subsequently, sorting motifs in the core domain
of Nef cause the tethering to a variety of intracellular vesicular
organelles that might mediate at least some of Nef's effects on
intracellular transport of surface receptors. The mechanisms
involved in the specificity of Nef to select cellular membranes
and its initial transport to the plasma membrane as well as the
potential biological role of non-membrane-associated Nef will
be subject to future studies.
Materials and methods
Cells and reagents
HeLa, 293T, TZM (JC53BL) and TZM clone 13 cells
(subcloned for high expression of MHC-I by fluorescence-
activated cell sorting) were maintained in DMEM high medium
(from GIBCO, Karlsruhe, Germany) supplemented with 10%
fetal calf serum (Invitrogen, Karlsruhe, Germany), L-glutamine
and antibiotics (both from GIBCO). Jurkat TAg (expressing the
large T antigen of SV-40 and referred to as Jurkat T-cells) and
CHO hCD4hCCR5 (stably expressing hCD4 and hCCR5,
described in Keppler et al., 2005) cells were cultured in RPMI
1640 (from GIBCO) medium supplemented accordingly. RPMI
for PBMC cultures was supplemented with 10% FCS, 0.1%
Glutamax (Invitrogen), 0.1% 1 M HEPES (pH 7.4) and
antibiotics.
Expression plasmids
Nef from HIV-1SF2 was used throughout the study.
Constructs encoding wild-type HIV-1SF2 Nef and the G2A,
Δ12–39, EDAA and AxxA mutants cloned into pEGFP-N1
(Invitrogen, Karlsruhe, Germany) have been described (Keppler
et al., 2005; Krautkramer et al., 2004). The deletion mutants
were generated by PCR with primers introducing BglII and
BshTI sites 5′- and 3′ of the nef amplicon, respectively, and
were subcloned in the BglII/BshTI digested pEGFP-N1 vector.
The expression plasmids for the WW, WMW, WR, R4, KK and
KR Nef variants as Nef.GFP fusion proteins were generated by
site-directed mutagenesis and subcloning. Isogenic proviral
constructs expressing various nef genes were constructed in the
backbone of the HIV-1NL4-3 proviral clone as described earlier
(Fackler et al., 2006). The complete nucleotide sequence of all
nef inserts of these proviral clones and the Nef.GFP expression
plasmids was verified by sequencing of both DNA strands.
Western blotting
For Western blot analysis, samples were boiled in SDS
Sample Buffer, separated by 10% SDS–PAGE and transferred
to a nitrocellulose membrane. Protein detection was performed
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antibodies using the super signal pico detection kit (Pierce,
Bonn, Germany) according to the manufacturer's instructions.
GFP constructs were detected with anti-GFP mouse monoclonal
antibody (BD Living Colors). CA and Nef were detected using
the polyclonal rabbit serum CA1 (Muller et al., 2004) and the
polyclonal sheep serum Arp444 (Coates et al., 1997),
respectively.
Live cell imaging
To visualize the subcellular localization of Nef, HeLa cells
were seeded on eight-chambered coverglasses (Lab-Tek, Nunc,
Rochester, New York) and transfected with Lipofectamine 2000
(Invitrogen) the next day. 24 h post-transfection, cells were
analyzed by confocal microscopy using an LSM 510 confocal
laser scanning microscope (Zeiss, Oberkochen, Germany).
Confocal images were processed with AdobePhotoshopCS2
software (Adobe Systems, Mountain View, CA).
Subcellular fractionation
Subcellular fractionation was performed using slight mod-
ifications of a previously described protocol (Alland et al.,
1994). In brief, 293T cells were transfected with Metafectene.
24 h post-transfection, cells were resuspended in hypotonic
buffer (10 mM Tris, pH 7.4, 0.2 mM MgCl2, protease inhibitor
cocktail) and homogenized by pipetting up and down for 50
times. Postnuclear supernatants were adjusted to 0.25M sucrose
and 1 mM EDTA and centrifuged at 100,000×g for 50 min.
Volumes of pellets (P) and supernatants (S) were equalized
using RIPA buffer (150 mM NaCl, 50 mM Tris–HCl, pH 7.2,
1% Triton-X 100, 0.1% SDS). 6× SDS Sample Buffer was
added and aliquots corresponding to 3% of the P and S fractions
or of the total cell lysate (IN) were analyzed byWestern Blotting
using antibodies against Nef, TfR (mAb H68.4, Zymed
Laboratories Inc., South San Francisco, CA) and 14-3-3 γ (C-
16, Santa Cruz Biotechnology, Heidelberg, Germany). For
quantification, films were scanned and the relative band
intensities were determined with the QuantityOne software
(BioRad) after background subtraction. The combined signal
intensity from the P and S fractions of each sample was set to
100% to yield the relative distribution of proteins between the P
and S fractions.
Raft flotation
293T cells were transfected with Lipofectamine 2000
(Invitrogen) and assay was performed using slight modifica-
tions of a previously described protocol (Krautkramer et al.,
2004). In brief, 24 h post-transfection, cells were lysed in ice-
cold TXNE (1% Triton X-100, 50 mM Tris–HCl pH 7.4,
150 mM NaCl, 5 mM EDTA, protease inhibitors) and incubated
for 20 min on ice. After homogenization by pipetting up and
down for 50 times, lysates were adjusted to 900 μl of 40%
Optiprep (Life Technologies, Karlsruhe, Germany) and over-
layed with 2.5 ml of 28% Optiprep and 0.5 ml of TXNE. Afterultracentrifugation (SW60 Ti rotor, 35.000 rpm, 4 °C, 3 h) eight
fractions of 500 μl were collected from the top. 2.5% of the
detergent-resistant membrane fraction (fraction 2) and the
pooled non-raft fractions (fractions 7 and 8), respectively, were
analyzed together with 0.5% of the unfractionated cell lysate by
Western Blotting.
Flow cytometry
CHO hCD4hCCR5 or TZM clone13 cells were transfected
with Nef.GFP expression constructs, respectively. Cells were
harvested 24 h post-transfection and CHO hCD4hCCR5 cells
were stained with anti-hCD4-APC and anti-hCCR5-APC (BD)
antibodies and TZM clone 13 cells with anti-MHC-I (W6/32-
FITC, Sigma-Aldrich, St. Louis, MO), respectively. All cell
surface molecules were stained at 4 °C for 30 min and samples
were analyzed by flow cytometry using a FACSCalibur
cytometer (Becton Dickinson, San Jose, CA).
In vitro kinase assay (IVKA)
In vitro kinase assay was performed as described earlier
(Krautkramer et al., 2004). Briefly, 1×107 Jurkat T-cells were
electroporated and 24 h later lysed in KEB (137 mM NaCl,
50 mM Tris–HCl pH 8, 2 mM EDTA, 0.5% Nonidet P-40,
Na3VO4, protease inhibitors). Postnuclear supernatants were
immunoprecipitated with anti-GFP antibodies. After intensive
wash in KEB, the immunoprecipitates were resuspended in
KAB (50 mM HEPES pH 8, 150 mM NaCl, 5 mM EDTA,
0.02% Triton X-100, 10 mM MgCl2) containing 10 μCi of [γ-
32P]ATP (Amersham, Freiburg, Germany) per reaction. After
incubation for 5 min, samples were washed and bound proteins
were separated by SDS–PAGE and subjected to autoradiogra-
phy. Quantification was performed on a phosphoimager
(BioRad, Munich, Germany) by using QuantityOne software
(BioRad).
Raft clustering
24 h post-transfection, Jurkat T-cells were incubated with
25 μg of Alexa 555- or Alexa 594-conjugated CTx/ml,
respectively, in 0.1% BSA/PBS for 30 min on ice. After
washing, cross-linking was performed by incubation with anti-
CTx antibody at a 1:200 dilution for 30 min at 4 °C and for
10 min at 37 °C. Cells were seeded on poly-L-lysine-coated
glass coverslips, fixed with 3% paraformaldehyde-PBS, washed
and mounted with Histoprime (Histogel, Linaris, Germany).
Fluorescence microscopy images were acquired with an LSM
510 confocal laser scanning microscope (Zeiss microscope with
a 100× oil-immersion objective equipped with a CCD camera)
and processed with AdobePhotoshopCS2 software (Adobe
Systems, Mountain View, CA).
Virus stocks and virion infectivity
Virus stocks were generated by transfection of proviral HIV
plasmids into 293T cells using Metafectene (Biontex
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culture supernatants were harvested. The CA concentration of
these virus stocks was determined by CA antigen enzyme-
linked immunosorbent assay (ELISA) as described (Muller et
al., 2004). The relative infectivity of HIV-1 particles was
determined by CA ELISA and a standardized 96-well TZM blue
cell assay as described (Keppler et al., 2005). Briefly, infections
were carried out in triplicates with 0.5 ng CA input virus. 36 h
post-infection, cells were fixed, stained for β-galactosidase
activity and the number of blue cells was determined by
microscopy.
Virion incorporation
For the analysis of virion incorporation of Nef, 400 μl of
cell culture supernatants containing infectious virions were
placed on top of 80 μl of a 20% sucrose solution. After
ultracentrifugation (TLA45 rotor, 44.000 rpm, 4 °C, 60 min),
the pellets were resuspended in 6× Sample Buffer. Volumes
corresponding to 100 or 5 ng CA were then analyzed by
Western blotting with antibodies against Nef and CA,
respectively.
Replication in primary human peripheral blood lymphocytes
(PBL)
To analyze the effects of Nef on HIV replication in primary
human T lymphocytes, peripheral blood mononuclear cells
were isolated from healthy donors by Ficoll gradients using
Ficoll-Paque Plus (Amersham Biosciences, Uppsala, Sweden).
For infection, cells were thawed and kept in bulk cultures in
RPMI, 10% FCS at 1×106 cells/ml over night. 1×105 cells/well
were then seeded in V-bottom 96-well plates and infected with
1 ng CA virus input per well the following day. 3 days later,
cells were washed and stimulated with 2 μg/ml PHA (Sigma)
and 20 nM IL-2 (Chiron, Emeryville, CA) for 3 days. After
stimulation, the PBL were washed and resuspended in 200 μl of
RPMI containing FCS and IL-2. Each day, 100 μl of cell culture
supernatant was replaced with fresh medium and amounts of
CA in the cell culture supernatant were quantified to monitor
virus replication.
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